Position in TSHA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$50,104,578
-$9,240,884 QoQ
Shares Held
11,209,078
+3.9% QoQ
Ownership
3.90%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 11.123484018935367.ToString("F0")%
Shared 0.ToString("F0")%
None 88.87651598106463.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. TSHA ranks #97 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in TSHA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,104,578 | 11,209,078 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $59,345,462 | 10,790,084 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $23,663,240 | 7,236,465 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,869,496 | 5,138,310 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,494,581 | 3,233,512 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,200,654 | 6,474,367 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,972,826 | 3,469,068 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,433,263 | 3,318,421 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $974,422 | 339,520 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $253,499 | 143,220 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $442,463 | 140,020 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $75,962 | 114,920 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $91,706 | 114,920 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $259,719 | 114,920 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $149,420 | 77,420 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $288,002 | 77,420 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,254,875 | 499,214 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,407,568 | 464,169 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,557,703 | 352,186 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,754,722 | 318,619 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,479,462 | 122,141 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $2,922,213 | 110,106 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||